Inovio Pharmaceuticals Inc. Stock Slips 3.9%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. shed 3.9% to $1.11 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the NASDAQ Composite Index falling 0.4% to 27,245.90.

Inovio Pharmaceuticals Inc. closed 59.4% below its 52-week high of $2.72, which the company achieved on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $263.73, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.42% to $28.40.

Trading volume totaled 2.3 million, compared to the 50-day average of 3.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 12, 2026 16:34 ET (20:34 GMT)